Concurrent RB1 Loss and <i>BRCA</i> Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma

Flurina A.M. Saner, Kazuaki Takahashi, Timothy Budden, Ahwan Pandey, Dinuka Ariyaratne, Tibor A. Zwimpfer, Nicola S. Meagher, Sian Fereday, Laura Twomey, Kathleen I. Pishas, Therese Hoang, Adelyn Bolithon, Nadia Traficante, Unknown, Kathryn Alsop, Elizabeth L. Christie, Eun-Young Kang, Gregg S. Nelson, Prafull Ghatage, Cheng-Han Lee, Marjorie J. Riggan, Jennifer Alsop, Matthias W. Beckmann, Jessica Boros, Alison H. Brand, Angela Brooks-Wilson, Michael E. Carney, Penny Coulson, Madeleine Courtney-Brooks, Kara L. Cushing-Haugen, Cezary Cybulski, Mona A. El-Bahrawy, Esther Elishaev, Ramona Erber, Simon A. Gayther, Aleksandra Gentry-Maharaj, C. Blake Gilks, Paul R. Harnett, Holly R. Harris, Arndt Hartmann, Alexander Hein, Joy Hendley, Brenda Y. Hernandez, Anna Jakubowska, Mercedes Jimenez-Linan, Michael E. Jones, Scott H. Kaufmann, Catherine J. Kennedy, Tomasz Kluz, Jennifer M. Koziak, Björg Kristjansdottir, Nhu D. Le, Marcin Lener, Jenny Lester, Jan Lubiński, Constantina Mateoiu, Sandra Orsulic, Matthias Ruebner, Minouk J. Schoemaker, Mitul Shah, Raghwa Sharma, Mark E. Sherman, Yurii B. Shvetsov, T. Rinda Soong, Helen Steed, Paniti Sukumvanich, Aline Talhouk, Sarah E. Taylor, Robert A. Vierkant, Chen Wang, Martin Widschwendter, Lynne R. Wilkens, Stacey J. Winham, Michael S. Anglesio, Andrew Berchuck, James D. Brenton, Ian Campbell, Linda S. Cook, Jennifer A. Doherty, Peter A. Fasching, Renée T. Fortner, Marc T. Goodman, Jacek Gronwald, David G. Huntsman, Beth Y. Karlan, Linda E. Kelemen, Usha Menon, Francesmary Modugno, Paul D.P. Pharoah, Joellen M. Schildkraut, Karin Sundfeldt, Anthony J. Swerdlow, Ellen L. Goode, Anna DeFazio, Martin Köbel, Susan J. Ramus, David D.L. Bowtell, Dale W. Garsed

Open source

DOI
10.1158/1078-0432.ccr-23-3552
Published
2024-06-05
Container
Clinical Cancer Research
Publisher
American Association for Cancer Research (AACR)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1158/1078-0432.ccr-23-3552,
  title = {Concurrent RB1 Loss and
                    <i>BRCA</i>
                    Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma},
  author = {Flurina A.M. Saner and Kazuaki Takahashi and Timothy Budden and Ahwan Pandey and Dinuka Ariyaratne and Tibor A. Zwimpfer and Nicola S. Meagher and Sian Fereday and Laura Twomey and Kathleen I. Pishas and Therese Hoang and Adelyn Bolithon and Nadia Traficante and Unknown and Kathryn Alsop and Elizabeth L. Christie and Eun-Young Kang and Gregg S. Nelson and Prafull Ghatage and Cheng-Han Lee and Marjorie J. Riggan and Jennifer Alsop and Matthias W. Beckmann and Jessica Boros and Alison H. Brand and Angela Brooks-Wilson and Michael E. Carney and Penny Coulson and Madeleine Courtney-Brooks and Kara L. Cushing-Haugen and Cezary Cybulski and Mona A. El-Bahrawy and Esther Elishaev and Ramona Erber and Simon A. Gayther and Aleksandra Gentry-Maharaj and C. Blake Gilks and Paul R. Harnett and Holly R. Harris and Arndt Hartmann and Alexander Hein and Joy Hendley and Brenda Y. Hernandez and Anna Jakubowska and Mercedes Jimenez-Linan and Michael E. Jones and Scott H. Kaufmann and Catherine J. Kennedy and Tomasz Kluz and Jennifer M. Koziak and Björg Kristjansdottir and Nhu D. Le and Marcin Lener and Jenny Lester and Jan Lubiński and Constantina Mateoiu and Sandra Orsulic and Matthias Ruebner and Minouk J. Schoemaker and Mitul Shah and Raghwa Sharma and Mark E. Sherman and Yurii B. Shvetsov and T. Rinda Soong and Helen Steed and Paniti Sukumvanich and Aline Talhouk and Sarah E. Taylor and Robert A. Vierkant and Chen Wang and Martin Widschwendter and Lynne R. Wilkens and Stacey J. Winham and Michael S. Anglesio and Andrew Berchuck and James D. Brenton and Ian Campbell and Linda S. Cook and Jennifer A. Doherty and Peter A. Fasching and Renée T. Fortner and Marc T. Goodman and Jacek Gronwald and David G. Huntsman and Beth Y. Karlan and Linda E. Kelemen and Usha Menon and Francesmary Modugno and Paul D.P. Pharoah and Joellen M. Schildkraut and Karin Sundfeldt and Anthony J. Swerdlow and Ellen L. Goode and Anna DeFazio and Martin Köbel and Susan J. Ramus and David D.L. Bowtell and Dale W. Garsed},
  year = {2024},
  journal = {Clinical Cancer Research},
  doi = {10.1158/1078-0432.ccr-23-3552},
  url = {https://doi.org/10.1158/1078-0432.ccr-23-3552}
}

RIS

TY  - JOUR
TI  - Concurrent RB1 Loss and
                    <i>BRCA</i>
                    Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma
AU  - Flurina A.M. Saner
AU  - Kazuaki Takahashi
AU  - Timothy Budden
AU  - Ahwan Pandey
AU  - Dinuka Ariyaratne
AU  - Tibor A. Zwimpfer
AU  - Nicola S. Meagher
AU  - Sian Fereday
AU  - Laura Twomey
AU  - Kathleen I. Pishas
AU  - Therese Hoang
AU  - Adelyn Bolithon
AU  - Nadia Traficante
AU  - Unknown
AU  - Kathryn Alsop
AU  - Elizabeth L. Christie
AU  - Eun-Young Kang
AU  - Gregg S. Nelson
AU  - Prafull Ghatage
AU  - Cheng-Han Lee
AU  - Marjorie J. Riggan
AU  - Jennifer Alsop
AU  - Matthias W. Beckmann
AU  - Jessica Boros
AU  - Alison H. Brand
AU  - Angela Brooks-Wilson
AU  - Michael E. Carney
AU  - Penny Coulson
AU  - Madeleine Courtney-Brooks
AU  - Kara L. Cushing-Haugen
AU  - Cezary Cybulski
AU  - Mona A. El-Bahrawy
AU  - Esther Elishaev
AU  - Ramona Erber
AU  - Simon A. Gayther
AU  - Aleksandra Gentry-Maharaj
AU  - C. Blake Gilks
AU  - Paul R. Harnett
AU  - Holly R. Harris
AU  - Arndt Hartmann
AU  - Alexander Hein
AU  - Joy Hendley
AU  - Brenda Y. Hernandez
AU  - Anna Jakubowska
AU  - Mercedes Jimenez-Linan
AU  - Michael E. Jones
AU  - Scott H. Kaufmann
AU  - Catherine J. Kennedy
AU  - Tomasz Kluz
AU  - Jennifer M. Koziak
AU  - Björg Kristjansdottir
AU  - Nhu D. Le
AU  - Marcin Lener
AU  - Jenny Lester
AU  - Jan Lubiński
AU  - Constantina Mateoiu
AU  - Sandra Orsulic
AU  - Matthias Ruebner
AU  - Minouk J. Schoemaker
AU  - Mitul Shah
AU  - Raghwa Sharma
AU  - Mark E. Sherman
AU  - Yurii B. Shvetsov
AU  - T. Rinda Soong
AU  - Helen Steed
AU  - Paniti Sukumvanich
AU  - Aline Talhouk
AU  - Sarah E. Taylor
AU  - Robert A. Vierkant
AU  - Chen Wang
AU  - Martin Widschwendter
AU  - Lynne R. Wilkens
AU  - Stacey J. Winham
AU  - Michael S. Anglesio
AU  - Andrew Berchuck
AU  - James D. Brenton
AU  - Ian Campbell
AU  - Linda S. Cook
AU  - Jennifer A. Doherty
AU  - Peter A. Fasching
AU  - Renée T. Fortner
AU  - Marc T. Goodman
AU  - Jacek Gronwald
AU  - David G. Huntsman
AU  - Beth Y. Karlan
AU  - Linda E. Kelemen
AU  - Usha Menon
AU  - Francesmary Modugno
AU  - Paul D.P. Pharoah
AU  - Joellen M. Schildkraut
AU  - Karin Sundfeldt
AU  - Anthony J. Swerdlow
AU  - Ellen L. Goode
AU  - Anna DeFazio
AU  - Martin Köbel
AU  - Susan J. Ramus
AU  - David D.L. Bowtell
AU  - Dale W. Garsed
PY  - 2024
JO  - Clinical Cancer Research
DO  - 10.1158/1078-0432.ccr-23-3552
UR  - https://doi.org/10.1158/1078-0432.ccr-23-3552
ER  - 

APA

Saner, F. A., Takahashi, K., Budden, T., Pandey, A., Ariyaratne, D., Zwimpfer, T. A., Meagher, N. S., Fereday, S., Twomey, L., Pishas, K. I., Hoang, T., Bolithon, A., Traficante, N., Unknown, Alsop, K., Christie, E. L., Kang, E., Nelson, G. S., Ghatage, P., Lee, C., Riggan, M. J., Alsop, J., Beckmann, M. W., Boros, J., Brand, A. H., Brooks-Wilson, A., Carney, M. E., Coulson, P., Courtney-Brooks, M., Cushing-Haugen, K. L., Cybulski, C., El-Bahrawy, M. A., Elishaev, E., Erber, R., Gayther, S. A., Gentry-Maharaj, A., Gilks, C. B., Harnett, P. R., Harris, H. R., Hartmann, A., Hein, A., Hendley, J., Hernandez, B. Y., Jakubowska, A., Jimenez-Linan, M., Jones, M. E., Kaufmann, S. H., Kennedy, C. J., Kluz, T., Koziak, J. M., Kristjansdottir, B., Le, N. D., Lener, M., Lester, J., Lubiński, J., Mateoiu, C., Orsulic, S., Ruebner, M., Schoemaker, M. J., Shah, M., Sharma, R., Sherman, M. E., Shvetsov, Y. B., Soong, T. R., Steed, H., Sukumvanich, P., Talhouk, A., Taylor, S. E., Vierkant, R. A., Wang, C., Widschwendter, M., Wilkens, L. R., Winham, S. J., Anglesio, M. S., Berchuck, A., Brenton, J. D., Campbell, I., Cook, L. S., Doherty, J. A., Fasching, P. A., Fortner, R. T., Goodman, M. T., Gronwald, J., Huntsman, D. G., Karlan, B. Y., Kelemen, L. E., Menon, U., Modugno, F., Pharoah, P. D., Schildkraut, J. M., Sundfeldt, K., Swerdlow, A. J., Goode, E. L., DeFazio, A., Köbel, M., Ramus, S. J., Bowtell, D. D., & Garsed, D. W. (2024). Concurrent RB1 Loss and <i>BRCA</i> Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-23-3552

Source records